Our analysis showed that when HER2 expression increases from ‘negative’ to ‘equivocal’ and further to ‘positive’, the expression patterns were correlated with clinical factors such as age, sex, tumour size, depth of invasion, histology, and lympho-vascular invasion in all EGC patients. This evidence concerns the gene ERBB2 and neoplasm.